Latus Bio

Latus | Where delivery transforms treatment

United States · Founded 2024 · $54.0M raised

Founded
2024
Business Model
B2B
Total Funding
$54.0M
Last Round
$54.0M Series AMay 2024
Rounds
1

About

Latus Bio develops investigational gene therapies using proprietary adeno-associated-virus capsids engineered for potency, specificity, and manufacturability. Its discovery approach combines tissue- and cell-specific capsid screening, optimized administration routes, regulatory elements, and computational models to improve delivery while reducing dose and manufacturing requirements. The company is advancing candidates for central-nervous-system and peripheral diseases from laboratories in Philadelphia and Boston.

Summary

Latus Bio is a Biotech company based in United States, founded in 2024. It has raised $54.0M in total across 1 round, most recently a $54.0M Series A round in May 2024. Investors include 8VC, DCVC (Data Collab) and Samsung Life Science Fund.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AMay 2024
$54.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Latus Bio on Indexed.vc
<a href="https://indexed.vc/companies/latus-bio"><img src="https://indexed.vc/api/badge/company/latus-bio" alt="Latus Bio on Indexed.vc" width="260" height="76" /></a>